Developer docs
API playgroundTry for free, no card

Search company profiles

WEPREDIC

Full company profile

uuid002qdrb

Namestring
WEPREDIC
Legal namestring
Wepredic SARL
Websiteurl
wepredic.com
Company typeenum
Private
Founded yearint
1990
Descriptiontext

WEPREDIC is a privately held French biotech group headquartered in Saint-Grégoire (Rennes metropolitan area), operating since the 1990s through multiple entities: Wepredic SARL (parent), Biopredic International SARL (assay manufacturing), Eurosafe (safety and bioavailability assessment services), Starlight (smart chemical probe synthesis), and Biopredic Inc. The group provides chemo-biological models and in vitro testing solutions for assessing the fate and safety of drugs, cosmetics, and industrial compounds, serving pharmaceutical companies, cosmetics manufacturers (named logos include Sephora, Nuxe, Pierre Fabre, and Yves Rocher), industrial chemical producers, and academic research institutions.

The core technology platform centers on two proprietary human liver cell models — HepaRG® (an established human hepatoma cell line used for drug metabolism, CYP induction, hepatotoxicity, steatosis, cholestasis, genotoxicity, and virology studies) and HepaSH™ (experimental human hepatocytes with lower inter-individual variation than primary human hepatocytes, used for cholestatic DILI prediction and hepatic clearance studies). These cell models anchor a broader catalog of transporter substrates and inhibitors (OCT1, OATP1B3, OAT1/2, OCT, MRP2/Pgp), fluorescent probes (Fluobile bile canaliculi probes, Fluoalb™ albumin probes), and assay reagents organized across DMPK, genotoxicity, hepatotoxicity, CYP P450, and non-genotoxic carcinogen categories. The cell lines have been continuously validated through a scientific publication record dating to 2006.

WEPREDIC generates revenue through three complementary streams: (1) one-time product sales of biochemical reagents and cell models via a direct e-commerce storefront at unit prices typically ranging from €45–€95, (2) contract safety and bioavailability assessment services delivered through Eurosafe (including volunteer studies for cosmetic testing), and (3) biological assay system sales through Biopredic. The go-to-market combines direct e-commerce for catalog products, sales-led engagement for services (phone + contact form), and event-driven outreach through participation in toxicology conferences such as SOT and SSX India. Distribution is global via the e-commerce channel and includes active geographic expansion efforts into Japan (Tokyo Metropolitan Government engagement, Feb 2026) alongside continued EMEA operations.

Short descriptiontext

WEPREDIC is a French biotech group providing proprietary in vitro liver cell models (HepaRG®, HepaSH™), chemical probes, and safety/bioavailability assessment services for pharmaceutical, cosmetics, and industrial compound manufacturers, serving clients including Sephora, Pierre Fabre, and Yves Rocher.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersOlivet, France
HQ citystring
Olivet
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
in vitro toxicology, cell-based assays, drug safety testing, liver cell models, biotech safety assessment
Industry1 code
PRIMARYHLAGAFAI
Pathology & Histopathology Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code3 codes
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
  • Biological Products, (No Disgnostic Substances)2836
Product category
Biotechnology Research Products
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Product Sales
TypeOne Time License
Description

Sale of biochemical compounds including transporter inhibitors, substrates, reference standards, cell culture products, and fluorescent probes through e-commerce platform. Products priced per unit (e.g., €45-95 per item).

wepredic.com
2Safety & Bioavailability Assessment Services (Eurosafe)
TypeProfessional Services
Description

Contract research services for safety assessment and bioavailability testing, including studies on volunteers for cosmetic testing.

wepredic.com
3Assay Systems (Biopredic)
TypeHardware Sales
Description

Manufacture and sale of biological assay systems for drug discovery and toxicology research.

wepredic.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Reference compounds sold as single units
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Examples: Prazosin €45.00, Cholecystokinin 8 €95.00 (both incl. tax). Prices vary by compound type and specifications.

wepredic.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 7 records shown
1Biopredic
Description

Biological assay systems - manufactures and markets assay products including HepaRG cells and HepaSH hepatocytes

wepredic.com
+6 more records
Core offering1 text field

WEPREDIC is a French biotech group that develops, manufactures, and sells proprietary human liver cell models (HepaRG® and HepaSH™), reference compounds (transporter substrates/inhibitors), and fluorescent probes for in vitro safety testing. Through its Eurosafe subsidiary it delivers contract safety and bioavailability assessment services, and through Starlight it designs chemical probes — all targeted at pharmaceutical, cosmetics, and industrial compound customers seeking human-relevant, animal-free toxicology data.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

WEPREDIC is a French biotech group providing chemo-biological models for assessing the fate and safety of drugs, cosmetics, and industrial compounds. The group consists of three core operating subsidiaries: Biopredic International (which manufactures and markets assay systems), Eurosafe (which provides safety and bioavailability assessment services), and Starlight (which designs and synthesizes smart chemical probes). The portfolio includes two proprietary liver cell models — HepaRG® and HepaSH™ — which serve as the foundation for the company's in vitro testing solutions. These are complemented by a broad catalog of reference compounds (transporter substrates and inhibitors), fluorescent probes (Fluobile and Fluoalb™ lines), and assay reagents organized across DMPK, genotoxic, hepatotoxic, endocrine disruptor, CYP P450, and non-genotoxic carcinogen product categories. The group serves multinational cosmetics and pharmaceutical companies including Sephora, Nuxe, Pierre Fabre, and Yves Rocher.

Product and service2 records
1Biopredic International Biological Assay Systems
CategoryBiological Assay Systems
2Eurosafe Safety & Bioavailability Assessment Services
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1Tokyo Metropolitan Government
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-02-01
Description

Visit by Tokyo Metropolitan Government representatives as part of ongoing collaborations with Japanese stakeholders. Discussion focused on expansion of Wepredic entities in Japan and contribution to Japanese market development in innovative in vitro technologies.

wepredic.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-06-01
Description

Educational exchange partnership for New Approach Methodologies (NAMs) training using HepaRG cell model. Remote real-time training video sessions with more than 50 students attending. Focused on 2-D HepaRG cell culture basics and practical cell culture techniques.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-06-01
Description

Collaborative partner in NAMs educational exchange program. Contributed to interactive sessions on generating complex microtissues, data management, analysis, and visualization. More than 50 students attended from their School of Life Sciences.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-06-01
Description

Partner in NAMs training initiative providing expertise in data management, analysis, and visualization. Contributed to interactive sessions alongside university partners.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialized CRO offering in vitro ADME/DMPK, hepatotoxicity, and transporter assay services. Direct overlap with Eurosafe's safety/bioavailability assessment services and Biopredic's DMPK/transporter product lines.

TypeBroad incumbent
Description

Diversified life sciences tools leader with Gibco cell culture products, primary hepatocytes, and toxicology assay platforms. Overlaps with WEPREDIC on in vitro hepatic models and ADME reagents, though serves a much broader customer base.

TypeDirect peer
Description

Supplier of human biospecimens, primary hepatocytes, and ADME/toxicology research services. Comparable to WEPREDIC in supplying hepatic cell models and supporting in vitro safety and metabolism studies for pharma/cosmetics clients.

4Corning Life Sciences
TypeBroad incumbent
Description

Major cell culture and life sciences tools supplier (e.g., HepatoSure hepatocytes, Matrigel). Comparable to Biopredic on cell-based assay and hepatic culture product lines.

TypeEmerging player
Description

Provider of cell-based assay reagents, luminescent/fluorescent probes, and ADME/toxicology kits. Comparable to Starlight's fluorescent probe products (Fluobile, Fluoalb) and Biopredic's assay reagent lines.

TypeBroad incumbent
Description

Contract research organization providing safety assessment, DMPK, and toxicology services across drug and chemical industries. Overlaps with Eurosafe's contract safety and bioavailability business on the services side.

TypeBroad incumbent
Description

Global contract development and manufacturing organization with a substantial cell biology and hepatic products portfolio (e.g., primary hepatocytes, HepatoSure). Highly relevant as a large incumbent competing in the same in vitro hepatic model and ADME/DMPK space as WEPREDIC, though much broader in scope.

TypeDirect peer
Description

Provider of hepatic products (human hepatocytes), subcellular fractions, and ADME/DMPK services for drug safety assessment. Closely comparable to WEPREDIC on hepatic models and DMPK services.

9Cellartis (Takara Bio)
TypeEmerging player
Description

Developer of iPSC-derived hepatic cell models for drug discovery and toxicology. Adjacent emerging competitor to HepaRG/HepaSH, particularly as pharma clients shift toward iPSC-based alternatives for DILI and DMPK applications.

TypeBroad incumbent
Description

Global testing services group with a large cosmetics/personal care testing and in vitro safety assessment offering. Direct overlap with Eurosafe's cosmetic safety testing services for cosmetics clients like Sephora and Yves Rocher.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

WEPREDIC

Biotechnology Research Productswepredic.com

WEPREDIC is a French biotech group providing proprietary in vitro liver cell models (HepaRG®, HepaSH™), chemical probes, and safety/bioavailability assessment services for pharmaceutical, cosmetics, and industrial compound manufacturers, serving clients including Sephora, Pierre Fabre, and Yves Rocher.

What WEPREDIC does

WEPREDIC is a privately held French biotech group headquartered in Saint-Grégoire (Rennes metropolitan area), operating since the 1990s through multiple entities: Wepredic SARL (parent), Biopredic International SARL (assay manufacturing), Eurosafe (safety and bioavailability assessment services), Starlight (smart chemical probe synthesis), and Biopredic Inc. The group provides chemo-biological models and in vitro testing solutions for assessing the fate and safety of drugs, cosmetics, and industrial compounds, serving pharmaceutical companies, cosmetics manufacturers (named logos include Sephora, Nuxe, Pierre Fabre, and Yves Rocher), industrial chemical producers, and academic research institutions.

The core technology platform centers on two proprietary human liver cell models — HepaRG® (an established human hepatoma cell line used for drug metabolism, CYP induction, hepatotoxicity, steatosis, cholestasis, genotoxicity, and virology studies) and HepaSH™ (experimental human hepatocytes with lower inter-individual variation than primary human hepatocytes, used for cholestatic DILI prediction and hepatic clearance studies). These cell models anchor a broader catalog of transporter substrates and inhibitors (OCT1, OATP1B3, OAT1/2, OCT, MRP2/Pgp), fluorescent probes (Fluobile bile canaliculi probes, Fluoalb™ albumin probes), and assay reagents organized across DMPK, genotoxicity, hepatotoxicity, CYP P450, and non-genotoxic carcinogen categories. The cell lines have been continuously validated through a scientific publication record dating to 2006.

WEPREDIC generates revenue through three complementary streams: (1) one-time product sales of biochemical reagents and cell models via a direct e-commerce storefront at unit prices typically ranging from €45–€95, (2) contract safety and bioavailability assessment services delivered through Eurosafe (including volunteer studies for cosmetic testing), and (3) biological assay system sales through Biopredic. The go-to-market combines direct e-commerce for catalog products, sales-led engagement for services (phone + contact form), and event-driven outreach through participation in toxicology conferences such as SOT and SSX India. Distribution is global via the e-commerce channel and includes active geographic expansion efforts into Japan (Tokyo Metropolitan Government engagement, Feb 2026) alongside continued EMEA operations.

WEPREDIC firmographics

Firmographics
Name
WEPREDIC
Legal name
Wepredic SARL
Website
https://wepredic.com
Company type
Private
Founded year
1990
Operating status
Operating
Headcount range
1–10 employees
Short description
WEPREDIC is a French biotech group providing proprietary in vitro liver cell models (HepaRG®, HepaSH™), chemical probes, and safety/bioavailability assessment services for pharmaceutical, cosmetics, and industrial compound manufacturers, serving clients including Sephora, Pierre Fabre, and Yves Rocher.
Ownership category
akta.pro rank

WEPREDIC industry classification

Industry
Product category
Biotechnology Research Products
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAGAFAI
Pathology & Histopathology Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Preclinical Services (Toxicology/Pharmacology/DMPK)

Keywords

  • In vitro toxicology
  • Cell-based assays
  • Drug safety testing
  • Liver cell models
  • Biotech safety assessment

Where WEPREDIC is headquartered

Location

Headquarters

HQ city
Olivet
HQ country
France
HQ region
Europe

Offices1 record

Markets served

WEPREDIC business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Product Sales: Sale of biochemical compounds including transporter inhibitors, substrates, reference standards, cell culture products, and fluorescent probes through e-commerce platform. Products priced per unit (e.g., €45-95 per item).
  2. Safety & Bioavailability Assessment Services (Eurosafe): Contract research services for safety assessment and bioavailability testing, including studies on volunteers for cosmetic testing.
  3. Assay Systems (Biopredic): Manufacture and sale of biological assay systems for drug discovery and toxicology research.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goReference compounds sold as single units

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

WEPREDIC product offering

Product offering

Core offering

WEPREDIC is a French biotech group that develops, manufactures, and sells proprietary human liver cell models (HepaRG® and HepaSH™), reference compounds (transporter substrates/inhibitors), and fluorescent probes for in vitro safety testing. Through its Eurosafe subsidiary it delivers contract safety and bioavailability assessment services, and through Starlight it designs chemical probes — all targeted at pharmaceutical, cosmetics, and industrial compound customers seeking human-relevant, animal-free toxicology data.

Product overview

WEPREDIC is a French biotech group providing chemo-biological models for assessing the fate and safety of drugs, cosmetics, and industrial compounds. The group consists of three core operating subsidiaries: Biopredic International (which manufactures and markets assay systems), Eurosafe (which provides safety and bioavailability assessment services), and Starlight (which designs and synthesizes smart chemical probes). The portfolio includes two proprietary liver cell models — HepaRG® and HepaSH™ — which serve as the foundation for the company's in vitro testing solutions. These are complemented by a broad catalog of reference compounds (transporter substrates and inhibitors), fluorescent probes (Fluobile and Fluoalb™ lines), and assay reagents organized across DMPK, genotoxic, hepatotoxic, endocrine disruptor, CYP P450, and non-genotoxic carcinogen product categories. The group serves multinational cosmetics and pharmaceutical companies including Sephora, Nuxe, Pierre Fabre, and Yves Rocher.

Differentiator

Problem solved

Functional benefit

Brands

  • Biopredic: Biological assay systems - manufactures and markets assay products including HepaRG cells and HepaSH hepatocytes
  • Eurosafe
  • Starlight
  • HepaRG
  • HepaSH
  • Fluoalb
  • Fluobile

Products and services

  • Biopredic International Biological Assay Systems
  • Eurosafe Safety & Bioavailability Assessment Services

Companies that use WEPREDIC

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

WEPREDIC technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

WEPREDIC partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered minor and core.

  • Tokyo Metropolitan GovernmentminorStrategic or Co-development Partner · 1 February 2026Visit by Tokyo Metropolitan Government representatives as part of ongoing collaborations with Japanese stakeholders. Discussion focused on expansion of Wepredic entities in Japan and contribution to Japanese market development in innovative in vitro technologies.
  • Lebanese University (UL)coreStrategic or Co-development Partner · 1 June 2021Educational exchange partnership for New Approach Methodologies (NAMs) training using HepaRG cell model. Remote real-time training video sessions with more than 50 students attending. Focused on 2-D HepaRG cell culture basics and practical cell culture techniques.
  • University of Applied Sciences and Arts Northwestern Switzerland (FHNW)coreStrategic or Co-development Partner · 1 June 2021Collaborative partner in NAMs educational exchange program. Contributed to interactive sessions on generating complex microtissues, data management, analysis, and visualization. More than 50 students attended from their School of Life Sciences.
  • Edeilwess Connect GmbH (Edw)coreStrategic or Co-development Partner · 1 June 2021Partner in NAMs training initiative providing expertise in data management, analysis, and visualization. Contributed to interactive sessions alongside university partners.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

WEPREDIC competitors and assessment

Company assessment

Direct peers

  • Cyprotex (an Evotec company): Specialized CRO offering in vitro ADME/DMPK, hepatotoxicity, and transporter assay services. Direct overlap with Eurosafe's safety/bioavailability assessment services and Biopredic's DMPK/transporter product lines.
  • BioIVT: Supplier of human biospecimens, primary hepatocytes, and ADME/toxicology research services. Comparable to WEPREDIC in supplying hepatic cell models and supporting in vitro safety and metabolism studies for pharma/cosmetics clients.
  • Sekisui Xenotech: Provider of hepatic products (human hepatocytes), subcellular fractions, and ADME/DMPK services for drug safety assessment. Closely comparable to WEPREDIC on hepatic models and DMPK services.

Broad incumbents

  • Thermo Fisher Scientific: Diversified life sciences tools leader with Gibco cell culture products, primary hepatocytes, and toxicology assay platforms. Overlaps with WEPREDIC on in vitro hepatic models and ADME reagents, though serves a much broader customer base.
  • Corning Life Sciences: Major cell culture and life sciences tools supplier (e.g., HepatoSure hepatocytes, Matrigel). Comparable to Biopredic on cell-based assay and hepatic culture product lines.
  • Inotiv: Contract research organization providing safety assessment, DMPK, and toxicology services across drug and chemical industries. Overlaps with Eurosafe's contract safety and bioavailability business on the services side.
  • Lonza: Global contract development and manufacturing organization with a substantial cell biology and hepatic products portfolio (e.g., primary hepatocytes, HepatoSure). Highly relevant as a large incumbent competing in the same in vitro hepatic model and ADME/DMPK space as WEPREDIC, though much broader in scope.
  • Eurofins Scientific: Global testing services group with a large cosmetics/personal care testing and in vitro safety assessment offering. Direct overlap with Eurosafe's cosmetic safety testing services for cosmetics clients like Sephora and Yves Rocher.

Emerging players

  • Promega Corporation: Provider of cell-based assay reagents, luminescent/fluorescent probes, and ADME/toxicology kits. Comparable to Starlight's fluorescent probe products (Fluobile, Fluoalb) and Biopredic's assay reagent lines.
  • Cellartis (Takara Bio): Developer of iPSC-derived hepatic cell models for drug discovery and toxicology. Adjacent emerging competitor to HepaRG/HepaSH, particularly as pharma clients shift toward iPSC-based alternatives for DILI and DMPK applications.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

WEPREDIC social profiles

Digital presence

WEPREDIC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

WEPREDIC leadership team

Management profile

Number of profiles

Profiles1 record

WEPREDIC subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

WEPREDIC funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

WEPREDIC M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WEPREDIC

What does WEPREDIC do?

WEPREDIC is a French biotech group that develops, manufactures, and sells proprietary human liver cell models (HepaRG® and HepaSH™), reference compounds (transporter substrates/inhibitors), and fluorescent probes for in vitro safety testing. Through its Eurosafe subsidiary it delivers contract safety and bioavailability assessment services, and through Starlight it designs chemical probes — all targeted at pharmaceutical, cosmetics, and industrial compound customers seeking human-relevant, animal-free toxicology data.

Is WEPREDIC a public or private company?

WEPREDIC is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was WEPREDIC founded?

WEPREDIC was founded in 1990. It employs 1 to 10 people.

Where is WEPREDIC based?

WEPREDIC is headquartered in Olivet, France, in the Europe region.

How does WEPREDIC make money?

Three revenue lines are on record. Product Sales are the primary driver. The others are safety & Bioavailability Assessment Services (Eurosafe) and assay Systems (Biopredic).

Who are WEPREDIC's main competitors?

Direct peers on record are Cyprotex (an Evotec company), BioIVT and Sekisui Xenotech. Broad incumbents are Thermo Fisher Scientific, Corning Life Sciences, Inotiv, Lonza and Eurofins Scientific. Emerging players are Promega Corporation and Cellartis (Takara Bio).

Does WEPREDIC have an API?

No public API is recorded for WEPREDIC.

What industry is WEPREDIC in?

WEPREDIC's product category is Biotechnology Research Products. Its primary akta.pro industry code is HLAGAFAI, Pathology & Histopathology Services. Its NAICS code is 541714 and its SIC code is 8734.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales